FDA Approves 11 Generics for Plavix

The FDA approved 11 generic competitors to Plavix on May 17, the day the blockbuster drug lost its patent protection.

Plavix (clopidogrel bisulfate) is a blood thinning drug prescribed to reduce the risk of heart attack and stroke.

IMS Health says Plavix brought in $42.8 billion for Bristol Myers Sqibb during the 15 years it was on the market.

Plavix is the second largest selling drug to lose patent protection after Lipitor which lost its patent protection last year.

FDA Announcement on Plavix Generics